Ghent University

CathVision to Present Predictive Filtering Capabilities of ECGenius System at EHRA 2024

Retrieved on: 
Monday, April 8, 2024

COPENHAGEN, Denmark, April 8, 2024 /PRNewswire/ -- CathVision today announced data from the PVISION trial demonstrating the ability of the ECGenius System's predictive noise filter to increase the time window before noise saturates PV potentials during PVI procedures. The data will be presented in a poster presentation at EHRA 2024.1

Key Points: 
  • COPENHAGEN, Denmark, April 8, 2024 /PRNewswire/ -- CathVision today announced data from the PVISION trial demonstrating the ability of the ECGenius System's predictive noise filter to increase the time window before noise saturates PV potentials during PVI procedures.
  • Key data points include:
    Of the 68 veins treated, 33 exhibited power line noise on one or more bipolar traces during the freeze cycle (49%).
  • "When we employed the predictive filter using the ECGenius System, the noise was eliminated from the electrogram data during the PVI procedure.
  • For more information about ECGenius System and CARDIALYTICS, or to meet with CathVision at EHRA 2024, please contact us and connect on LinkedIn .

"All United for MG" coalition launches a petition to advocate change in Myasthenia Gravis

Retrieved on: 
Wednesday, March 6, 2024

BRUSSELS, March 6, 2024 /PRNewswire/ -- Following Rare Disease Day and in anticipation of the European elections, All United for MG has undertaken the initiative to mobilize society, initiating transformative changes for the patient community. Since its establishment in 2023, All United for MG has been amplifying the generalised Myasthenia Gravis (gMG) patient voice across Europe. A Call for Action, launched with European parliamentarians Tomislav Sokol and Istvan Ujhelyi in June 2023 during the first-ever Myasthenia Gravis Day, contains six actionable policy recommendations for the improvement of the visibility, recognition and treatment of Myasthenia Gravis (MG) and other rare diseases. These recommendations were supported by over 30 stakeholders, including 11 members of the European Parliament, healthcare professionals and Patient Advocacy Groups (PAGs). All United for MG is now intensifying its efforts and seeks the support of all citizens across Europe by launching a petition on change.org, to encourage the civil society to support and advocate for changes in the management of rare diseases care,especially in generalized Myasthenia Gravis (gMG). The ambition is to collect between 5.000 - 10.000 signatures in the lead-up to the second Myasthenia Gravis Awareness Day on June 2nd and the European elections. 

Key Points: 
  • In the context of Autoimmune Awareness Month, the coalition of patients suffering from Myasthenia Gravis (MG) "All United for MG" urges citizens throughout Europe to unite in instigating positive change and enhancing Myasthenia Gravis management.
  • All United for MG is officially launching a European petition to advocate for better rights for patients and their caregivers, improved access to healthcare and enhanced conditions.
  • Since its establishment in 2023, All United for MG has been amplifying the generalised Myasthenia Gravis (gMG) patient voice across Europe.
  • "Rare diseases often struggle for visibility in political discourse, making the All United for MG petition all the more important.

"All United for MG" coalition launches a petition to advocate change in Myasthenia Gravis

Retrieved on: 
Wednesday, March 6, 2024

BRUSSELS, March 6, 2024 /PRNewswire/ -- Following Rare Disease Day and in anticipation of the European elections, All United for MG has undertaken the initiative to mobilize society, initiating transformative changes for the patient community. Since its establishment in 2023, All United for MG has been amplifying the generalised Myasthenia Gravis (gMG) patient voice across Europe. A Call for Action, launched with European parliamentarians Tomislav Sokol and Istvan Ujhelyi in June 2023 during the first-ever Myasthenia Gravis Day, contains six actionable policy recommendations for the improvement of the visibility, recognition and treatment of Myasthenia Gravis (MG) and other rare diseases. These recommendations were supported by over 30 stakeholders, including 11 members of the European Parliament, healthcare professionals and Patient Advocacy Groups (PAGs). All United for MG is now intensifying its efforts and seeks the support of all citizens across Europe by launching a petition on change.org, to encourage the civil society to support and advocate for changes in the management of rare diseases care,especially in generalized Myasthenia Gravis (gMG). The ambition is to collect between 5.000 - 10.000 signatures in the lead-up to the second Myasthenia Gravis Awareness Day on June 2nd and the European elections. 

Key Points: 
  • In the context of Autoimmune Awareness Month, the coalition of patients suffering from Myasthenia Gravis (MG) "All United for MG" urges citizens throughout Europe to unite in instigating positive change and enhancing Myasthenia Gravis management.
  • All United for MG is officially launching a European petition to advocate for better rights for patients and their caregivers, improved access to healthcare and enhanced conditions.
  • Since its establishment in 2023, All United for MG has been amplifying the generalised Myasthenia Gravis (gMG) patient voice across Europe.
  • "Rare diseases often struggle for visibility in political discourse, making the All United for MG petition all the more important.

Why Taylor Swift belongs on English literature degree courses

Retrieved on: 
Tuesday, January 2, 2024

When I started my podcast, Studies in Taylor Swift, in the spring of 2021, I felt that I was simultaneously helping to invent, and trying to catch up to, the academic discipline of Taylor Swift studies.

Key Points: 
  • When I started my podcast, Studies in Taylor Swift, in the spring of 2021, I felt that I was simultaneously helping to invent, and trying to catch up to, the academic discipline of Taylor Swift studies.
  • I went on to design a summer school course at Queen Mary University of London on Taylor Swift and Literature in 2023.

Dear reader

  • We talked about the line “You drew stars around my scars / But now I’m bleedin’”.
  • The idea was to try to figure out how the “but” worked – whether the scars had reopened or new ones had been created.
  • It is also a song about the speaker herself, someone who keeps getting “marooned” on the shores of the past.

Hits different

  • On the other hand, there is clearly something about the idea of classes on Taylor Swift as literature that catches the popular imagination.
  • In media discussions, her name is sometimes juxtaposed with another one: Shakespeare.
  • The Times published Bate’s article alongside a quiz asking readers whether Swift or Shakespeare had written a particular line.
  • But this is born from a popular misconception about what it is we do in literature classes – even Shakespeare classes.


Clio Doyle teaches a class on Taylor Swift and Literature at the Queen Mary Summer School.

IriusRisk Hosts Fireside Chat with Artificial Intelligence & Machine Learning Industry Leaders

Retrieved on: 
Tuesday, November 28, 2023

up your security and compliance efforts with leaders in AI, ML and regulations.

Key Points: 
  • up your security and compliance efforts with leaders in AI, ML and regulations.
  • Dr. Gary McGraw, Cofounder of Berryville Institute of Machine Learning (BIML) and Chairman of IriusRisk's Technical Advisory Board.
  • McGraw is a globally recognized authority on software security and author of eight best-selling books.
  • De Roovere has collaborated on a wide range of privacy and security consultancy and is a guest lecturer on cybersecurity trends and management at Ghent University.

RayzeBio Appoints Industry Leader Tim Van Hauwermeiren to Its Board of Directors

Retrieved on: 
Wednesday, November 1, 2023

SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- RayzeBio, Inc. (Nasdaq: RYZB), a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, today announced the appointment of Tim Van Hauwermeiren to its board of directors.

Key Points: 
  • SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- RayzeBio, Inc. (Nasdaq: RYZB), a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, today announced the appointment of Tim Van Hauwermeiren to its board of directors.
  • I see a lot of parallels between RayzeBio and argenx and look forward to leveraging my experience to help RayzeBio unlock the full potential of this emerging modality,” said Tim.
  • Tim Van Hauwermeiren co-founded argenx and has served as Chief Executive Officer since 2008.
  • “I am thrilled to welcome Tim to our board of directors,” said Ken Song, M.D., President and CEO of RayzeBio.

IFF Celebrates Achievements of Leading Scientists Across Multiple Fields

Retrieved on: 
Tuesday, October 24, 2023

NEW YORK, Oct. 24, 2023 /PRNewswire/ -- IFF (NYSE: IFF)—an industry leader in food, beverage, health, biosciences and scent—this week will celebrate groundbreaking achievements in science excellence. Dr. Filip Van Immerseel and Dr. Jack A. Gilbert will receive the IFF Science and Microbiome Science Awards, for their research advancements in the fields of animal nutrition & health and microbiome.[1] Additionally, IFF scientist Dr. Philippe Horvath is being inducted into the National Inventors Hall of Fame® (NIHF) on Oct. 26 for his seminal research on CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) that helped revolutionize the gene editing field.

Key Points: 
  • "At IFF, we believe honoring scientific excellence from our scientists and academics is a great tribute to our heritage of innovation," said Dr. Casper Vroemen, executive vice president, chief R&D and sustainability officer, IFF.
  • "On behalf of the IFF scientific community, I'm proud to celebrate three renowned scientists who are pushing the limits of science to create a better world."
  • IFF Science Award: Filip Van Immerseel of Ghent University, Belgium, was selected for his groundbreaking work in animal nutrition & health.
  • IFF, the IFF Logo, and all trademarks and service marks denoted with TM, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted.

Register Now for the 4th International Conference on Innovative Intelligent Industrial Production and Logistics (Rome, Italy - November 15-17, 2023) - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 12, 2023

El-Houssaine Aghezzaf, Ghent University, Faculty of Engineering and Architecture, Belgium

Key Points: 
  • El-Houssaine Aghezzaf, Ghent University, Faculty of Engineering and Architecture, Belgium
    Nouha Baccour, National Engineering School of Sfax of the University of Sfax, Tunisia
    Patrick Brandtner, University of Applied Sciences Steyr, Austria
    Hing Kai Chan, University of Nottingham Ningbo China, China
    Xavier Delorme, Ecole Nationale Superieure des Mines de Saint-Etienne, France
    Mikael Gidlund, Department of Information Systems and Technology (IST), Mid Sweden University, Sweden
    Manuel Gilberto Gilberto Santos, Polytechnic Institute of Cavado and Ave, Portugal
    Virginie Goepp, Institut National des Sciences Appliquees de Strasbourg, France
    Zivana Jakovljevic, University of Belgrade - Faculty of Mechanical Engineering, Serbia
    Arkadiusz Kawa, Institute of Logistics and Warehousing, Poland
    Manas Khatua, Indian Institute of Technology Guwahati, India
    Andre Andrade Longaray, Federal Foundation University of Rio Grande, Brazil
    Sergio Martin, UNED - Spanish University for Distance Education, Spain
    Rafal Michalski, Wroclaw University of Science and Technology, Poland
    Christian Neureiter, Salzburg University of Applied Sciences, Austria
    Yaodong Ni, University of International Business and Economics, China
    Anthony M. M. Pagano, University of Illinois at Chicago, United States
    Vikram Sharma, The LNM Institute of Information Technology, India
    Neeraj Kumar Singh, National School Electrical Electronics Computer Hydraulics Telecommunications, France

Register Now for the 4th International Conference on Innovative Intelligent Industrial Production and Logistics (Rome, Italy - November 15-17, 2023)

Retrieved on: 
Saturday, October 7, 2023

El-Houssaine Aghezzaf, Ghent University, Faculty of Engineering and Architecture, Belgium

Key Points: 
  • El-Houssaine Aghezzaf, Ghent University, Faculty of Engineering and Architecture, Belgium
    Nouha Baccour, National Engineering School of Sfax of the University of Sfax, Tunisia
    Patrick Brandtner, University of Applied Sciences Steyr, Austria
    Hing Kai Chan, University of Nottingham Ningbo China, China
    Xavier Delorme, Ecole Nationale Superieure des Mines de Saint-Etienne, France
    Mikael Gidlund, Department of Information Systems and Technology (IST), Mid Sweden University, Sweden
    Manuel Gilberto Gilberto Santos, Polytechnic Institute of Cavado and Ave, Portugal
    Virginie Goepp, Institut National des Sciences Appliquees de Strasbourg, France
    Zivana Jakovljevic, University of Belgrade - Faculty of Mechanical Engineering, Serbia
    Arkadiusz Kawa, Institute of Logistics and Warehousing, Poland
    Manas Khatua, Indian Institute of Technology Guwahati, India
    Andre Andrade Longaray, Federal Foundation University of Rio Grande, Brazil
    Sergio Martin, UNED - Spanish University for Distance Education, Spain
    Rafal Michalski, Wroclaw University of Science and Technology, Poland
    Christian Neureiter, Salzburg University of Applied Sciences, Austria
    Yaodong Ni, University of International Business and Economics, China
    Anthony M. M. Pagano, University of Illinois at Chicago, United States
    Vikram Sharma, The LNM Institute of Information Technology, India
    Neeraj Kumar Singh, National School Electrical Electronics Computer Hydraulics Telecommunications, France

FUBON by Angel Yeast: Professional Yeast Solution for Sustainable Nutrition in Farming

Retrieved on: 
Wednesday, October 4, 2023

FUBON by Angel Yeast is a global leader of yeast-based products for animal nutrition committed to pushing forward green, ecological farming leveraging cutting-edge yeast technologies, promoting environmental protection, and fulfilling social responsibility.

Key Points: 
  • FUBON by Angel Yeast is a global leader of yeast-based products for animal nutrition committed to pushing forward green, ecological farming leveraging cutting-edge yeast technologies, promoting environmental protection, and fulfilling social responsibility.
  • FUBON by Angel Yeast offers solutions that enhance animal digestion, boost immunity, and reduce antibiotic use, ensuring animal health and safety.
  • "FUBON by Angel Yeast aims to provide new solutions for the health of people and animals.
  • To learn more about Angel Animal Nutrition, please visit https://en.angelyeast.com/products/animal-nutrition.html
    View original content to download multimedia: https://www.prnewswire.com/news-releases/fubon-by-angel-yeast-profession...